Sanofi ends marketing deal with developer of inhaled insulin - The Boston Globe

Sanofi ends marketing deal with developer of inhaled insulin - The Boston Globe | marketing - Google News | January 05, 2016 at 10:32PM

The Boston Globe

Sanofi ends marketing deal with developer of inhaled insulin The Boston Globe MannKind, based in Valencia, Calif., said in a news release Tuesday that the companies would try to effect a smooth transition of the marketing rights from Sanofi to MannKind, to be completed in no later than six months. It said it was reviewing its ... Sanofi to stop marketing Afrezza, citing low RxMedical Marketing and Media MannKind plans to seek new marketing partner for insulin drugLos Angeles Times all 71 news articles »

January 05, 2016 at 10:32PM | marketing - Google News
Sanofi ends marketing deal with developer of inhaled insulin - The Boston Globe
marketing - Google News